Agonizing and Exorbitant: The 'Super Drugs' That Couldn't Save My Father’s Life

The family of a health-care reporter for TheMarker, Haaretz's business publication, confronts the astronomical cost of potentially lifesaving immunotherapy treatment for cancer.

comments Print
It was just a matter of time until the tough issues that I have been writing about for more than a decade would hit closer to home. In April 2014, my dad, Danny, contracted a fairly rare form of cancer with...